Global In-Vitro Diagnostics Market Briefing 2018: PoC Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology and Immunohematology - ResearchAndMarkets.com

DUBLIN--()--The "In Vitro Diagnostics Market Global Briefing 2018" report has been added to ResearchAndMarkets.com's offering.

The In-Vitro Diagnostics Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.

In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person's state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation.

In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens.

Asia Pacific was the largest region in the in-vitro diagnostics market in 2017, accounting for around 32% market share. North America was the second largest region accounting for around 26% market share. Africa was the smallest region accounting for around 4% market share.

Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. for instance, in February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature's expertise in both next-generation sequencing (NGS) assays and biobanks.

In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space

Scope:

  • Markets Covered: Point-of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology and Immunohematology
  • Time Series: Five years historic and forecast.
  • Data: Market value in $ billions.
  • Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Danaher (Beckman Coulter Inc)
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • bioMrieux
  • Sysmex Corporation
  • Becton Dickinson & Company

For more information about this report visit https://www.researchandmarkets.com/research/pmwznk/global_invitro?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics